| 1. | Thornton M. The 78 kDa glucose regulated protein (GRP78) as a potential treatment predictive biomarker and therapeutic target in colorectal cancer adjuvant chemotherapy [dissertation]. Liverpool (UK): University of Liverpool; 2014. (FC) | | 2. | Peres RS, Liew FY, Talbot J, Carregaro V, Oliveira RD, Almeida SL, et al. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc Natl Acad Sci USA. 2015;112:2509-14. (FC) |
|
|
ApoScreen® is a registered trademark of SouthernBiotechnology Associates, Inc.
|